Related references
Note: Only part of the references are listed.Impact of Long-Term HFD Intake on the Peripheral and Central IGF System in Male and Female Mice
Santiago Guerra-Cantera et al.
METABOLITES (2020)
Use of online recruitment strategies in a randomized trial of cancer survivors
Stephen P. Juraschek et al.
CLINICAL TRIALS (2018)
Effects of 2-year calorie restriction on circulating levels of IGF-1, IGF-binding proteins and cortisol in nonobese men and women: a randomized clinical trial
Luigi Fontana et al.
AGING CELL (2016)
Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer
Dongge Cai et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Adiposity and cancer risk: new mechanistic insights from epidemiology
Andrew G. Renehan et al.
NATURE REVIEWS CANCER (2015)
Effects of Metformin on Endometrial Cancer Cell Growth in Vivo: A Preoperative Prospective Trial
Akira Mitsuhashi et al.
CANCER (2014)
Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
Emelie Karnevi et al.
BMC CANCER (2013)
Effects of Dietary Weight Loss and Exercise on Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-Binding Protein-3 in Postmenopausal Women: A Randomized Controlled Trial
Caitlin Mason et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Metformin and cancer
Christos V. Rizos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer
Catherine Duggan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers
E. S. Schernhammer et al.
CANCER CAUSES & CONTROL (2012)
AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern
D. Grahame Hardie et al.
CHEMISTRY & BIOLOGY (2012)
A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1-2 and-3 in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Francesca L. Crowe et al.
ANNALS OF HUMAN BIOLOGY (2011)
Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
Emily Jane Gallagher et al.
YEAR IN DIABETES AND OBESITY (2011)
Metformin and digestive disorders
M. Bouchoucha et al.
DIABETES & METABOLISM (2011)
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women
M. N. Harvie et al.
INTERNATIONAL JOURNAL OF OBESITY (2011)
Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice
Lawrence J. Appel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Normal values of serum IGF-1 in adults: results from a Brazilian population
Pedro Weslley Rosario
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
Regan M. Memmott et al.
CANCER PREVENTION RESEARCH (2010)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults
David Berrigan et al.
GROWTH HORMONE & IGF RESEARCH (2009)
Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
Joseph E. Donnelly et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2009)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy
B Berker et al.
GYNECOLOGICAL ENDOCRINOLOGY (2004)
Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women
NE Allen et al.
CANCER CAUSES & CONTROL (2003)
Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)
A Lukanova et al.
CANCER CAUSES & CONTROL (2002)
Share Paper
